Cristal Therapeutics

Provides nanomedicines based ON CriPec platform for cancer and inflammation disorder

placeMaastricht, Limburg, Netherlands calendar_todayFounded 2011 groups6 employees language cristaltherapeutics.com

Social engagement

Social engagement: 2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include BioGeneration Ventures, Brightlands Venture Partners, Aglaia, Droia Ventures.

Investor typeCountShare
Venture capital764%
Accelerator & incubator218%
Other / undisclosed218%

Recent activity

8 Jun 2026
Product launch
CliCr®
5 May 2026
Product launch
CliCr®
28 Apr 2026
Product launch
CliCr platform with Curapath
Coming soon